Research Article
[Retracted] Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy
Table 1
The disease name and sample number in TCGA data.
| | Disease | Code | Tumor samples | Percentage |
| | Bladder urothelial carcinoma | BLCA | 301 | 3.9025% | | Breast invasive carcinoma | BRCA | 1056 | 13.6912% | | Cervical squamous cell carcinoma and endocervical adenocarcinoma | CESC | 258 | 3.3450% | | Colon adenocarcinoma | COAD | 451 | 5.8473% | | Glioblastoma multiforme | GBM | 153 | 1.9837% | | Head and neck squamous cell carcinoma | HNSC | 480 | 6.2233% | | Kidney renal clear cell carcinoma | KIRC | 526 | 6.8197% | | Kidney renal papillary cell carcinoma | KIRP | 222 | 2.8783% | | Acute myeloid leukemia | LAML | 173 | 2.2430% | | Brain lower grade glioma | LGG | 439 | 5.6917% | | Liver hepatocellular carcinoma | LIHC | 294 | 3.8117% | | Lung adenocarcinoma | LUAD | 486 | 6.3011% | | Lung squamous cell carcinoma | LUSC | 428 | 5.5491% | | Ovarian serous cystadenocarcinoma | OV | 261 | 3.3839% | | Pancreatic adenocarcinoma | PAAD | 142 | 1.8410% | | Prostate adenocarcinoma | PRAD | 379 | 4.9138% | | Rectum adenocarcinoma | READ | 153 | 1.9837% | | Skin cutaneous melanoma | SKCM | 80 | 1.0372% | | Stomach adenocarcinoma | STAD | 415 | 5.3805% | | Thyroid carcinoma | THCA | 500 | 6.4826% | | Uterine corpus endometrial carcinoma | UCEC | 516 | 6.6900% | | Total | | 7713 | |
|
|
